Share on StockTwits

Petmed Express (NASDAQ:PETS) Director Ronald J. Korn sold 2,000 shares of Petmed Express stock on the open market in a transaction dated Friday, August 15th. The stock was sold at an average price of $14.13, for a total transaction of $28,260.00. Following the transaction, the director now directly owns 78,333 shares in the company, valued at approximately $1,106,845. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Separately, analysts at Zacks reiterated a “neutral” rating on shares of Petmed Express in a research note on Friday, July 25th. They now have a $15.00 price target on the stock.

Shares of Petmed Express (NASDAQ:PETS) traded up 2.00% during mid-day trading on Monday, hitting $14.29. The stock had a trading volume of 200,988 shares. Petmed Express has a 1-year low of $12.13 and a 1-year high of $17.21. The stock’s 50-day moving average is $13.75 and its 200-day moving average is $13.39. The company has a market cap of $285.2 million and a P/E ratio of 15.40.

Petmed Express (NASDAQ:PETS) last released its earnings data on Monday, July 21st. The company reported $0.25 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.25. The company had revenue of $72.50 million for the quarter, compared to the consensus estimate of $74.25 million. During the same quarter in the prior year, the company posted $0.24 earnings per share. The company’s quarterly revenue was down 2.3% on a year-over-year basis. On average, analysts predict that Petmed Express will post $0.91 earnings per share for the current fiscal year.

PetMed Express, Inc (NASDAQ:PETS) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.